Test Price
900 AED✅ Home Collection Available
HLA-DR3 (DRB1*03) Typing Test in UAE | 900 AED | 2026 DHA Guidelines
تحليل HLA-DR3 (DRB1*03) في الإمارات | 900 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – This definitive HLA-DR3 genotyping test delivers 99.9% diagnostic sensitivity via ISO 9001:2015 accredited Luminex® reverse SSOP methodology. Paid hospital‑grade home collection with cold‑chain integrity and VIP mobile phlebotomy ensures sample viability from your doorstep. Every report includes telephonic post‑test clinical guidance. Insurance coverage can be verified instantly by sending your policy card to WhatsApp +971 54 548 8731.
ملخص تنفيذي – فحص جيني حديث لتحديد أليل HLA-DRB1*03، المرتبط بأمراض المناعة الذاتية مثل الداء البطني والسكري من النوع الأول والذئبة الحمامية الجهازية. يُجرى بضمان جودة عالية وفقًا لمعايير هيئة الصحة بدبي لعام 2026. خدمة سحب منزلي معتمدة وسلسلة تبريد دقيقة، إلى جانب استشارة طبية هاتفية لتفسير النتائج. تحقق من تغطية التأمين عبر واتساب +971545488731.
Overview
The HLA-DR3 (DRB1*03) Typing Test detects the specific allele of the human leukocyte antigen system strongly associated with autoimmune pathogenesis. It provides a critical piece of the clinical puzzle, enabling early risk stratification and tailored monitoring plans for conditions frequently managed by dermatologists, general physicians, and primary care doctors.
اختبار جيني لتحديد أليل HLA-DRB1*03 يُستخدم لتقييم احتمالية الإصابة بالأمراض المناعية الذاتية تحت إشراف أطباء الجلدية والرعاية الأولية.
| Feature | Our HLA-DR3 | Closest Alternative |
|---|---|---|
| Precision | High‑resolution reverse SSOP (Luminex) with 99.9% allele‑level accuracy | Low‑resolution PCR‑SSP with potential ambiguous allele assignment |
| Method | CE‑marked Luminex platform, FDA‑listed reagents | Conventional gel‑based PCR |
| Speed | 10‑12 working days with digital report | 14‑21 days, often requiring repeat testing |
Physician Insight & Safety Protocol
“As a DHA‑licensed consultant dermatologist, I order HLA‑DR3 testing to untangle complex presentations like dermatitis herpetiformis or early photosensitive lupus. A positive result does not confirm disease; it must be weighed against clinical symptoms, autoantibody panels, and family history. Please never modify immunosuppressive therapy based solely on a genetic report – always return to your physician for integrated interpretation.”
– Dr. Prabhakar Reddy (DHA: 61713011)
Critical Medication Warning
Do not discontinue any prescribed medication, especially corticosteroids, immunomodulators, or biologic agents, without explicit advice from your treating physician. Abrupt cessation can provoke a severe flare of an autoimmune condition.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection or fever >38.5 °C – postpone venipuncture.
- ECOG performance status ≥3 – contact us for assisted collection.
- Known severe needle phobia or vasovagal syncope – inform the phlebotomist.
Seek immediate emergency care if you experience: chest pain, difficulty breathing, uncontrolled bleeding, or signs of anaphylaxis post‑collection.
Patient FAQ & Clinical Guidance
Q: What does a positive HLA-DR3 result really mean for my health?
A: A positive result indicates you carry the HLA‑DR3 allele, which raises your lifetime risk for specific autoimmune disorders such as coeliac disease, type 1 diabetes, and lupus, but it is not a diagnosis. Clinical correlation with symptoms, serology, and expert consultation is essential to differentiate genetic predisposition from active disease.
Q: How should I prepare for the home blood draw, and can I take my usual medicines?
A: No fasting or special preparation is needed; you are strongly advised to continue all prescribed medications unless your doctor instructs otherwise. Keep the sample tube refrigerated after collection – our phlebotomist will immediately place it in a validated cold-chain carrier for transport to the ISO‑certified laboratory.
س: هل يغطي التأمين تكلفة الاختبار، ومتى أحصل على النتيجة؟
ج: معظم خطط التأمين المحلية تغطي فحص HLA‑DR3 عند وجود توجيه طبي واضح، ويُمكننا التحقق من التغطية خلال دقائق عبر واتساب. تُصدر النتيجة المخبرية الرقمية خلال ١٠ إلى ١٢ يوم عمل وتُرسل بتقرير معتمد من هيئة الصحة بدبي.
Regulatory & Quality Compliance
All testing is performed under Federal Decree‑Law No. 41 of 2024 (Art. 87), the UAE PDPL data protection framework, and CDS Law 2026 for minors. Laboratory facility license 9834453, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Sample logistics strictly adhere to DHA/MOHAP cold‑chain requirements.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians